Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

ABSTRACT Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. Materials and Methods This was a 52‐week, prospective, observational study. Fifty Jap...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshiki Kogai, Junko Sato, Haruna Yasuda, Tatsuhiro Ayame, Azusa Ozaki, Eri Takagi, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.14350
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575019924848640
author Toshiki Kogai
Junko Sato
Haruna Yasuda
Tatsuhiro Ayame
Azusa Ozaki
Eri Takagi
Mami Koshibu
Yuya Nishida
Fuki Ikeda
Hirotaka Watada
author_facet Toshiki Kogai
Junko Sato
Haruna Yasuda
Tatsuhiro Ayame
Azusa Ozaki
Eri Takagi
Mami Koshibu
Yuya Nishida
Fuki Ikeda
Hirotaka Watada
author_sort Toshiki Kogai
collection DOAJ
description ABSTRACT Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. Materials and Methods This was a 52‐week, prospective, observational study. Fifty Japanese people with type 1 diabetes switched from the MiniMed™ 640G to 770G, and we analyzed the continuous glucose monitoring data of 24 subjects who used auto mode throughout the study. We also analyzed the scores of the Diabetes Therapy‐Related Quality of Life questionnaire completed by 26 auto‐mode users before and after the treatment change. Results The baseline time in range 70–180 mg/dL was 67.3 (54.8–78.4)%, with a significant improvement beginning 8 weeks after the switch and lasting until 52 weeks. The baseline time below range <70 mg/dL was 1.9 (0.6–3.6)%, with a significant increase at week 8; however, the mean value was less than 4% throughout the study period. On the other hand, the number of blood glucose measurements significantly increased. While there was no significant difference in the overall change in the total Diabetes Therapy‐Related Quality of Life score, there was a significant decrease in the treatment satisfaction score. Conclusions Use of the MiniMed™ 770G improved continuous glucose monitoring metrics. However, treatment satisfaction decreased, probably due to the increased frequency of blood glucose monitoring necessary to maintain auto mode.
format Article
id doaj-art-6051f6793e8e4126817ad40fa7d6c709
institution Kabale University
issn 2040-1116
2040-1124
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj-art-6051f6793e8e4126817ad40fa7d6c7092025-02-01T10:02:01ZengWileyJournal of Diabetes Investigation2040-11162040-11242025-02-0116232633310.1111/jdi.14350Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitusToshiki Kogai0Junko Sato1Haruna Yasuda2Tatsuhiro Ayame3Azusa Ozaki4Eri Takagi5Mami Koshibu6Yuya Nishida7Fuki Ikeda8Hirotaka Watada9Department of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo JapanABSTRACT Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. Materials and Methods This was a 52‐week, prospective, observational study. Fifty Japanese people with type 1 diabetes switched from the MiniMed™ 640G to 770G, and we analyzed the continuous glucose monitoring data of 24 subjects who used auto mode throughout the study. We also analyzed the scores of the Diabetes Therapy‐Related Quality of Life questionnaire completed by 26 auto‐mode users before and after the treatment change. Results The baseline time in range 70–180 mg/dL was 67.3 (54.8–78.4)%, with a significant improvement beginning 8 weeks after the switch and lasting until 52 weeks. The baseline time below range <70 mg/dL was 1.9 (0.6–3.6)%, with a significant increase at week 8; however, the mean value was less than 4% throughout the study period. On the other hand, the number of blood glucose measurements significantly increased. While there was no significant difference in the overall change in the total Diabetes Therapy‐Related Quality of Life score, there was a significant decrease in the treatment satisfaction score. Conclusions Use of the MiniMed™ 770G improved continuous glucose monitoring metrics. However, treatment satisfaction decreased, probably due to the increased frequency of blood glucose monitoring necessary to maintain auto mode.https://doi.org/10.1111/jdi.14350Hybrid closed‐loop systemJapaneseType 1 diabetes
spellingShingle Toshiki Kogai
Junko Sato
Haruna Yasuda
Tatsuhiro Ayame
Azusa Ozaki
Eri Takagi
Mami Koshibu
Yuya Nishida
Fuki Ikeda
Hirotaka Watada
Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
Journal of Diabetes Investigation
Hybrid closed‐loop system
Japanese
Type 1 diabetes
title Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
title_full Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
title_fullStr Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
title_full_unstemmed Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
title_short Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus
title_sort effects of switching from minimed™ 640g to 770g on continuous glucose monitoring metrics and dtr qol scores an observational study of japanese people with type 1 diabetes mellitus
topic Hybrid closed‐loop system
Japanese
Type 1 diabetes
url https://doi.org/10.1111/jdi.14350
work_keys_str_mv AT toshikikogai effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT junkosato effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT harunayasuda effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT tatsuhiroayame effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT azusaozaki effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT eritakagi effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT mamikoshibu effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT yuyanishida effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT fukiikeda effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus
AT hirotakawatada effectsofswitchingfromminimed640gto770goncontinuousglucosemonitoringmetricsanddtrqolscoresanobservationalstudyofjapanesepeoplewithtype1diabetesmellitus